CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity Meeting Abstract
| Authors: | Zhang, Z.; Zhou, C.; Li, X.; Barnes, S.; Deng, S.; Hoover, E.; Chen, C. C.; Lee, Y. S.; Wang, C.; Tirado, C.; Metang, L.; Johnson, N.; Wongvipat, J.; Navrazhina, K.; Cao, Z.; Abida, W.; Lujambio, A.; Li, S.; Malladi, V.; Sawyers, C.; Mu, P. |
| Abstract Title: | CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059302400 |
| DOI: | 10.1158/1538-7445.Am2020-ng06 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: NG06 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
